🔎 Trials Near Me

Home › Respiratory Distress Syndrome › New Jersey

Respiratory Distress Syndrome clinical trials in New Jersey

8 studies for Respiratory Distress Syndrome are looking for participants at sites in New Jersey.

Cities in New Jersey

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

  • Goryeb Children's Hospital, Morristown
RecruitingPhase 3
1 Hour – 24 Hours · All sexes · Updated Aug 6, 2026 · NCT06776783

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

  • Robert Wood Johnson Medical School, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701669

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

  • Robert Wood Johnson Medical School, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701682

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

  • Robert Wood Johnson Medical School, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701656

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

  • Robert Wood Johnson Medical School, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06703073

A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

  • Cooper University Hospital, Camden
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Jun 23, 2026 · NCT05795465

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Inspira Medical Center, Mullica Hill
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077

InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS

  • Jersey Shore University Medical Center, Neptune City
RecruitingPhase 3
29 Weeks – 36 Weeks · All sexes · Updated Mar 30, 2025 · NCT05960929

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.